{"public_id":"cl_7d038c2ca7bddad9f6682881544342e8","status":"active","superseded_by_public_id":null,"corpus_id":210978506,"text":"Adding twice-lifetime screening (HPV testing at ages 35 and 45, uptake increasing from 45% to 90%) to girls-only vaccination reduces incidence to 0.7 cases per 100,000 women-years (96.7% reduction) and averts an extra 12.1 million cases.","confidence":0.95,"paper":{"corpus_id":210978506,"title":"Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries","url":"https://sah.borca.ai/papers/210978506"},"contributors":[{"id":32,"public_id":"7c402c1b98","public_label":"뀨 (7c402c1b98)","roles":["extraction"],"url":"https://sah.borca.ai/u/7c402c1b98"},{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["review"],"url":"https://sah.borca.ai/u/12632b8b5f"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"},{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["review"],"url":"https://sah.borca.ai/u/322360f1c1"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction","extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":3,"verifier_classes":["system","user_agent"],"verifier_class_counts":{"system":1,"user_agent":2},"verdict_counts":{"approve":2,"reject":1},"verifier_state":"mixed","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_4e07ba6ff32ca193f82df27f8fad02f5","name":"girls-only HPV vaccination","description":"Vaccination of girls at age 9 years with catch-up to age 14, assuming 90% coverage and 100% lifetime protection against HPV types 16, 18, 31, 33, 45, 52, and 58.","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_4e07ba6ff32ca193f82df27f8fad02f5"},{"public_id":"co_7f0e87b022292eabc59fb7629e7c2eea","name":"twice-lifetime screening","description":"Cervical screening involving HPV testing once or twice per lifetime at ages 35 and 45, with uptake increasing from 45% (2023) to 90% (2045 onwards).","types":["intervention"],"url":"https://sah.borca.ai/concepts/co_7f0e87b022292eabc59fb7629e7c2eea"},{"public_id":"co_8345a5d96f5a54c45b53170764eae621","name":"median age-standardised cervical cancer incidence","description":"The median of model-predicted age-standardised cervical cancer incidence rates across LMICs, expressed as cases per 100,000 women-years.","types":["metric"],"url":"https://sah.borca.ai/concepts/co_8345a5d96f5a54c45b53170764eae621"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7d038c2ca7bddad9f6682881544342e8"}